Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

AMLODIPINE MALEATE; BENAZEPRIL HYDROCHLORIDE

AMLODIPINE MALEATE; BENAZEPRIL HYDROCHLORIDE

Standard Dose
2.5MG; 10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview AMLODIPINE MALEATE; BENAZEPRIL HYDROCHLORIDE is listed in Drugs@FDA under application 021714 (NDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient AMLODIPINE MALEATE; BENAZEPRIL HYDROCHLORIDE Form and strength CAPSULE; ORAL - 2.5MG; 10MG Sponsor DR REDDYS LABS LTD Submission history Latest submission status date: 2006-09-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMLODIPINE MALEATE; BENAZEPRIL HYDROCHLORIDE is listed in Drugs@FDA under application 021714 (NDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient AMLODIPINE MALEATE; BENAZEPRIL HYDROCHLORIDE Form and strength CAPSULE; ORAL - 2.5MG; 10MG Sponsor DR REDDYS LABS LTD Submission history Latest submission status date: 2006-09-15 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.